Efficacy of micafungin for the treatment of candidemia

被引：7

作者：

Andes, D

Safdar, N

机构：

[1] Univ Wisconsin, Dept Med, Infect Dis Sect, Madison, WI 53792 USA

[2] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53792 USA

来源：

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 2005年 / 24卷 / 10期

关键词：

D O I：

10.1007/s10096-005-0025-7

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：662 / 664

页数：3

共 20 条

[1] A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients [J].

de Wet, N ;

Llanos-Cuentas, A ;

Suleiman, J ;

Baraldi, E ;

Krantz, EF ;

Della Negra, M ;

Diekmann-Berndt, H .

CLINICAL INFECTIOUS DISEASES, 2004, 39 (06) :842-849

[2] Echinocandin antifungal drugs [J].

Denning, DW .

LANCET, 2003, 362 (9390) :1142-1151

[3] Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans endophthalmitis [J].

Gauthier, GM ;

Nork, TM ;

Prince, R ;

Andes, D .

CLINICAL INFECTIOUS DISEASES, 2005, 41 (03) :E27-E28

[4] Attributable mortality of nosocomial candidemia, revisited [J].

Gudlaugsson, O ;

Gillespie, S ;

Lee, K ;

Berg, JV ;

Hu, JF ;

Messer, S ;

Herwaldt, L ;

Pfaller, M ;

Diekema, D .

CLINICAL INFECTIOUS DISEASES, 2003, 37 (09) :1172-1177

[5] Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program [J].

Hajjeh, RA ;

Sofair, AN ;

Harrison, LH ;

Lyon, GM ;

Arthington-Skaggs, BA ;

Mirza, SA ;

Phelan, M ;

Morgan, J ;

Lee-Yang, W ;

Ciblak, MA ;

Benjamin, LE ;

Sanza, LT ;

Huie, S ;

Yeo, SF ;

Brandt, ME ;

Warnock, DW .

JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (04) :1519-1527

[6] Antifungal susceptibility of Candida biofilms:: Unique efficacy of amphotericin B lipid formulations and echinocandins [J].

Kuhn, DM ;

George, T ;

Chandra, J ;

Mukherjee, PK ;

Ghannoum, MA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (06) :1773-1780

[7] Nosocomial candidemia in non-neutropenic patients at an Italian tertiary care hospital [J].

Luzzati, R ;

Amalfitano, G ;

Lazzarini, L ;

Soldani, F ;

Bellino, S ;

Solbiati, M ;

Danzi, MC ;

Vento, S ;

Todeschini, G ;

Vivenza, C ;

Concia, E .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2000, 19 (08) :602-607

[8] Comparison of caspofungin and amphotericin B for invasive candidiasis. [J].

Mora-Duarte, J ;

Betts, R ;

Rotstein, C ;

Colombo, AL ;

Thompson-Moya, L ;

Smietana, J ;

Lupinacci, R ;

Sable, C ;

Kartsonis, N ;

Perfect, J .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (25) :2020-2029

[9] THERAPEUTIC APPROACHES IN PATIENTS WITH CANDIDEMIA - EVALUATION IN A MULTICENTER, PROSPECTIVE, OBSERVATIONAL STUDY [J].

NGUYEN, MH ;

PEACOCK, JE ;

TANNER, DC ;

MORRIS, AJ ;

NGUYEN, ML ;

SNYDMAN, DR ;

WAGENER, MM ;

YU, VL .

ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (22) :2429-2435

[10]

Ostrosky-Zeichner L, 2003, CLIN INFECT DIS, V37, P415, DOI 10.1086/376634

← 1 2 →